Loading...
MYLAN INSTITUTIONAL INC 2898 — Moxifloxacin Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #3 buyer for Moxifloxacin · $831.4K import value · 18 shipments · UNITED STATES · DGFT Verified
MYLAN INSTITUTIONAL INC 2898 is the #3 importer of Moxifloxacin from India with $831.4K in import value and 18 verified shipments. MYLAN INSTITUTIONAL INC 2898 holds a 2.3% market share in Moxifloxacin imports based in UNITED STATES. The company sources from 1 verified supplier across 12 formulations shipped to 1 country. Overall, MYLAN INSTITUTIONAL INC 2898 imports 11 pharmaceutical products worth $26.8M across 8 therapeutic categories.
Verified from 18 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $831.4K | 18 | 100.0% |
MYLAN INSTITUTIONAL INC 2898 sources Moxifloxacin from 1 verified Indian supplier based on 18 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MYLAN INSTITUTIONAL INC 2898 ★ | UNITED STATES | $742.1K | 16 | $46.4K |
| 2 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $650.0K | 13 | $50.0K |
| 6 | AUROBINDO PHARMA USA., INC, | UNITED STATES | $442.3K | 9 | $49.1K |
MYLAN INSTITUTIONAL INC 2898 ranks #3 among 731 Moxifloxacin importers from India. Average shipment value of $46.4K compared to the market average of $8.0K. The closest competitors by value are AUROLOGISTICS LLC, (AUROBINDO PHARM and AUROBINDO PHARMA USA., INC,.
Destination countries from 18 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $831.4K | 18 | 100.0% |
MYLAN INSTITUTIONAL INC 2898 imports Moxifloxacin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $831.4K.
| Formulation | Value | Shipments |
|---|---|---|
| MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 | $335.7K | 7 |
| MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU67608639 TAX VAL 3952601.12 | $47.6K | 1 |
| MOXIFLOXACIN HCL INJ1.6MG/ML 12S US SU67608639 TAX VAL 3952601.12 | $47.6K | 1 |
| MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU67608711 TAX 3888726.19 | $46.8K | 1 |
| MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU67608712 TAX 3866900.37 | $46.5K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE INSODIUM CHLORID INJECTION(400MG/250ML0.8%SALINE)(1.6MG/ML)12S MYLAN US(3234578)VAL3904915.76 | $44.8K | 1 |
| MOXIFLOXACINHYDROCHLORIDE IN SODIUMCHLORIDE INJ400MG/250ML 0.8%SALINE 1.6MG/ML12SMYLANUS BNO:3234577 T-VALUE:3912238.29 | $44.7K | 1 |
| MOXIFLOXACIN HCL INJ-1.6MG/ML-12S-US-SU6BATCH NO:7608625 TAXABLE VALUE:3720116.53 |
What MYLAN INSTITUTIONAL INC 2898 and other importers must comply with to import Moxifloxacin from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $5.9M worth of Moxifloxacin through 2,413 shipments from 336 suppliers to 137 countries, serving 731 buyers globally. MYLAN INSTITUTIONAL INC 2898 imports $831.4K of this total, accounting for 2.3% of India's Moxifloxacin exports with 18 shipments from UNITED STATES. This is verified from 18 customs shipment records covering 12 distinct formulations.
MYLAN INSTITUTIONAL INC 2898's average Moxifloxacin order value is $46.2K per consignment, based on 18 shipments totaling $831.4K. MYLAN INSTITUTIONAL INC 2898 is based in UNITED STATES and ranks #3 among all Moxifloxacin importers from India by value. The company sources from 1 verified supplier in India.
MYLAN INSTITUTIONAL INC 2898 sources Moxifloxacin from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($831.4K, 100.0%). This is based on 18 customs records.
MYLAN INSTITUTIONAL INC 2898 ranks #3 among 731 Moxifloxacin importers from India with a 2.3% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($742.1K), AUROLOGISTICS LLC, (AUROBINDO PHARM ($650.0K), AUROBINDO PHARMA USA., INC, ($442.3K). MYLAN INSTITUTIONAL INC 2898 processed 18 shipments from UNITED STATES.
MYLAN INSTITUTIONAL INC 2898 imports 11 products worth $26.8M. Beyond Moxifloxacin, top products include Vancomycin, Famotidine, Amino, Docetaxel, Heparin. View the complete MYLAN INSTITUTIONAL INC 2898 profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Moxifloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for MYLAN INSTITUTIONAL INC 2898's Moxifloxacin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MYLAN INSTITUTIONAL INC 2898
Full Company Profile →
11 products · $26.8M total trade · 8 categories
| $44.6K |
| 1 |
| MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE INJECTION (400MG/250ML 0.8%SALINE)(1.6MG/ML)(12S)MYLANUS(3234513 | $43.7K | 1 |
| MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6(7610276) TAXVAL 3850453.11 | $43.7K | 1 |
MYLAN INSTITUTIONAL INC 2898 imports 12 distinct Moxifloxacin formulations from India. The top formulation is MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 with 7 shipments worth $335.7K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for MYLAN INSTITUTIONAL INC 2898.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Moxifloxacin. For current order-level data, contact TransData Nexus.